| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2017) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC14 |
| UNII: | NU90V55F8I |
Pharmacology
| Action | Mechanism of Action | Reference | |
|---|---|---|---|
| ANTAGONIST | Interleukin-6 receptor alpha subunit antagonist | PubMed |
| Primary Target | |
|---|---|
| Interleukin-6 receptor, α subunit |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference | ||
|---|---|---|---|---|---|
| Arthritis, Rheumatoid | 4 | D001172 | ClinicalTrials | ||
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials | ||
| Polymyalgia Rheumatica | 3 | D011111 | ClinicalTrials | ||
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials | ||
| Giant Cell Arteritis | 3 | D013700 | ClinicalTrials | ||
| Mastocytosis, Systemic | 2 | D034721 | ClinicalTrials | ||
| Arthritis, Juvenile | 2 | D001171 | ClinicalTrials | ||
| Uveitis | 2 | D014605 | ClinicalTrials | ||
| Spondylitis, Ankylosing | 2 | D013167 | ClinicalTrials | ||
| Scleroderma, Localized | 1 | D012594 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1189541-98-7 |
| ChEMBL | CHEMBL2108730 |
| FDA SRS | NU90V55F8I |
| Guide to Pharmacology | 7999 |
CONTENTS